Trials / Completed
CompletedNCT03997812
Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Vivozon, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VVZ-149 Injections | IV infusion of 1000 mg of VVZ-149 |
| DRUG | Placebo | IV infusion of 0 mg of VVZ-149 |
Timeline
- Start date
- 2019-05-23
- Primary completion
- 2019-08-07
- Completion
- 2019-08-21
- First posted
- 2019-06-25
- Last updated
- 2020-08-25
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03997812. Inclusion in this directory is not an endorsement.